Note: This document has been translated from the Japanese original for reference purpose only. In the event ofany discrepancy between this translated document and the Japanese original, the original shall prevail.

August 6, 2024

Noevir Holdings Announces Consolidated Results for the First Nine Months of
the Fiscal Year Ending September 30, 2024(based on Japan GAAP)
Trade name:
Listing:
URL:
Representative:
Contact:

Noevir Holdings Co., Ltd.
Tokyo Stock Exchange, Prime Market (Securities Code: 4928)
https://www.noevirholdings.co.jp/
Takashi Okura, President and CEO
Junya Baba, General Manager, Accounting
Tel. +81-78-303-5121
Date of commencement of dividend payments: –Supplemental materials for the financial results prepared: None
Results briefing for the reporting period held: None
(Amounts under one million yen have been rounded down)

1. Operating results for the first nine months of the fiscal year ending September 30, 2024
(October 1, 2023 to June 30, 2024)(1) Consolidated operating results(Millions of yen; percentage figures denote year-on-year change)

Net sales
Nine months ended June 30, 2024
Nine months ended June 30, 2023

48,238 2.9 %46,882 2.2 %Operatingincome
9,015
2.7 %
8,781
10.3 %

Note: Comprehensive income:Nine months ended June 30, 2024: 5,309 million yen [(2.6)%]
Nine months ended June 30, 2023: 5,450 million yen [11.9%]
EPS (Yen)
131.48137.48Nine months ended June 30, 2024
Nine months ended June 30, 2023

Diluted EPS (Yen)——(2) Consolidated financial position
As of June 30, 2024

Total assets
75,44377,246

Net assets
50,99953,205

As of September 30, 2023
[Reference] Equity:
As of June 30, 2024: 50,421 million yen
As of September 30, 2023: 52,790 million yen- 1 -Ordinary
income9,169 2.3 %8,959 10.2 %(Millions of yen)

Equity ratio (%)
66.8
68.3

Net income attributableto owners of the parent
4,490 (4.4) %
4,695
0.9 %

2. Cash dividends(Yen)
Annual dividends

Fiscal year ended September 30, 2023
Fiscal year ended September 30, 2024
Fiscal year ending September 30, 2024
(forecast)

1st quarter2nd quarter3rd quarter

Year-end

Total

—
—

0.00
0.00

—
—

220.00220.00220.00220.00Note: Revisions from the most recently announced dividend forecast: None

3. Consolidated earnings forecasts for the fiscal year ending September 30, 2024
(October 1, 2023 to September 30, 2024)(Millions of yen; percentage figures denote year-on-year change)

Net income
attributable toowners of the parent
Full year
63,0000.7% 11,200
1.6% 11,400
0.9%
7,800
1.6%
Note: Revisions from the most recently announced consolidated earnings forecast: None
Net sales

Operating income

Ordinary income

EPS (Yen)
228.36* Notes(1) Significant changes in the scope of consolidation during the period: None
(2) Special accounting treatment for preparation of quarterly consolidated financial statements: None
(3) Changes in accounting principles, procedures, disclosure methods, etc.
1) Changes associated with revision in accounting standards: None
2) Other changes: None
3) Changes in accounting estimates: None
4) Restatements: None
(4) Shares outstanding (common stock)
1) Shares outstanding (including treasury stock)
As of June 30, 2024:
34,156,623
As of September 30, 2023: 34,156,623
2) Treasury shares outstanding
As of June 30, 2024:
318
As of September 30, 2023: 270
3) Average shares outstanding over quarter
Nine months ended June 30, 2024: 34,156,345
Nine months ended June 30, 2023: 34,156,353* Review of the Japanese-language originals of the attached consolidated quarterly financial statements bycertified public accountants or an audit firm: None
* Explanation regarding the appropriate use of business performance forecasts
Forward-looking statements included in these materials, such as forecasts of business performance, are based on
information known to the Company’s management as of the time of writing, and reflect judgments believed to bereasonable on the basis of that information. There is, therefore, a possibility that actual business performance
figures will differ substantially from our forecasts as a result of changes in the economic situation and other
unforeseeable factors. Please refer to “(3) Estimates and forecasts pertaining to future plans and business results”
under “1. Qualitative information regarding quarterly consolidated business performance” on page 5 of the
Attached Material.

- 2 -Contents of the Attached Material
1. Operating results and financial information ........................................................................................ 4(1) Operating results for the first nine months of the fiscal year ending September 30, 2024 .............. 4(2) Financial position as of June 30, 2024 ............................................................................................. 4(3) Estimates and forecasts pertaining to future plans and business results .......................................... 5
2. Quarterly consolidated financial statements and notes........................................................................ 6(1) Quarterly consolidated balance sheets ............................................................................................. 6(2) Quarterly consolidated statements of income and comprehensive income ...................................... 8(3) Quarterly consolidated statements of cash flows ........................................................................... 10(4) Notes to the quarterly consolidated financial statements ............................................................... 11(Note on assumptions for going concern)...................................................................................... 11(Note on significant changes in the amount of shareholders’ equity)............................................ 11(Note on segment information) ..................................................................................................... 12

- 3 -

1.

Operating results and financial information(1) Operating results for the first nine months of the fiscal year ending September 30, 2024
Consolidated operating results for the first nine months of the fiscal year ending September 30, 2024
(October 1, 2023 to June 30, 2024)
Nine months ended
June 30, 2023
Net sales% of Total(Millions of yen)

Nine months ended
June 30, 2024
Net sales% of Total(Millions of yen)

Change(Millions of yen)

Change(%)

46,882100.0

48,238

100.0

1,356

2.9

Cosmetics

36,60078.1

38,099

79.0

1,498

4.1

Pharmaceuticals& Health Food

8,646

18.4

8,265

17.1

(381)

(4.4)

Other

1,634

3.5

1,873

3.9

238

14.6

Nine months ended
June 30, 2024
Amount% of Net sales(Millions of yen)

Change(Millions of yen)

Net sales

Nine months ended
June 30, 2023
Amount% of Net sales(Millions of yen)

Change(%)

Operating income

8,781

18.7

9,015

18.7

234

2.7

Ordinary income

8,959

19.1

9,169

19.0

210

2.3

Net income
attributable toowners of the parent

4,695

10.0

4,490

9.3

(204)

(4.4)

During the first nine months of fiscal 2024 (October 1, 2023 to June 30, 2024), economic trends remained
uncertain, although some signs of gradual recovery were observed.
In this environment, the Company is working to realize the concept of its medium-term management plan:“Realizing steady corporate growth by securing sustainability in every Group business segment.”
As a result, net sales for the first nine months of fiscal 2024 came to 48,238 million yen (up 2.9% year on year),
operating income was 9,015 million yen (up 2.7%), ordinary income was 9,169 million yen (up 2.3%),
and net income attributable to owners of the parent came to 4,490 million yen (down 4.4%).
In the Cosmetics segment, net sales totaled 38,099 million yen (up 4.1% year on year), and segment income
came to 9,606 million yen (up 3.0%).
In the Pharmaceuticals & Health Food segment, net sales totaled 8,265 million yen (down 4.4% year on year),and segment income came to 954 million yen (down 4.9%).
In the Other segment, net sales totaled 1,873 million yen (up 14.6% year on year), and segment income cameto 222 million yen (up 32.8%).

(2) Financial position as of June 30, 2024
Total assets as of June 30, 2024 stood at 75,443 million yen, a decrease of 1,803 million yen from the previous
fiscal year-end. This was mainly due to a decrease in other receivables of 1,578 million yen.
Total liabilities came to 24,443 million yen, an increase of 402 million yen from the previous fiscal year-end.
This mainly reflected an increase in notes and accounts payable of 520 million yen.
Net assets came to 50,999 million yen, a decrease of 2,205 million yen from the previous fiscal year-end.
This was primarily attributable to a decrease in retained earnings of 3,023 million yen, due to the payment of
7,514 million yen in dividends at the previous fiscal year-end, which was partly offset by net income attributableto owners of the parent of 4,490 million yen.
As a result, the equity ratio stood at 66.8%.

- 4 -(Consolidated cash flows)
Cash and cash equivalents (hereinafter, “cash”) on a consolidated basis as of the end of the period under review
stood at 28,091 million yen, an increase of 1,925 million yen compared with the previous fiscal year-end.
The status of each cash flow together with the factors contributing to their increase or decrease for the first ninemonths of fiscal 2024 are presented as follows.
(Cash flows from operating activities)
Net cash provided by operating activities amounted to 7,533 million yen (1,578 million yen more than in thecorresponding period of the previous fiscal year). The main item increasing cash was 9,185 million yen inincome before income taxes.
(Cash flows from investing activities)
Net cash provided by investing activities came to 1,781 million yen (an increase of 2,625 million yen from thenet cash used in the corresponding period of the previous fiscal year). The principal cash inflow was 2,697
million yen in proceeds from withdrawal of time deposits, whereas the principal cash outflows were 409 million
yen for purchase of property, plant and equipment and 336 million yen for purchase of intangible assets.
(Cash flows from financing activities)
Net cash used in financing activities came to 7,585 million yen (173 million yen more than in the corresponding
period of the previous fiscal year). This was mainly due to the payment of 7,520 million yen in dividends.

(3) Estimates and forecasts pertaining to future plans and business results
The consolidated business performance forecasts for the full year ending September 30, 2024, announced on
November 7, 2023, remain unchanged.

- 5 -

2.

Quarterly consolidated financial statements and notes(1) Quarterly consolidated balance sheets
Previous fiscal year
(As of September 30,
2023)

ASSETS
Current assets
Cash and cash equivalents
Notes and accounts receivable
Merchandise and finished goods
Work in progress
Raw materials and purchased supplies
Other receivables
Other
Allowance for doubtful accounts
Total current assets
Non-current assets
Property, plant and equipment
Buildings and structures, net
Equipment and vehicles, net
Land
Lease assets, net
Construction in progress
Other, net
Total property, plant and equipment
Intangible assets
Goodwill
Software
Other
Total intangible assets
Investments and other assets
Investment securities
Deferred tax assets
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets- 6 -(Millions of yen)
As ofJune 30, 2024

28,883
10,495
6,352
141
1,653
3,057
597
(6)
51,17528,30910,323
6,706
113
1,567
1,479
676
(6)
49,1694,887
650
13,554846
71
183
20,193

4,650
712
13,559786
3173
19,885

178
89
431
699

167
74
745
986

2,611
1,455
1,132
(20)
5,178
26,071
77,246

3,244
1,090
1,084
(18)
5,402
26,27375,443

Previous fiscal year
(As of September 30,
2023)
LIABILITIESCurrent liabilities
Notes and accounts payable
Lease obligations
Other accounts payable
Income tax payable
Reserve for bonuses
Other
Total current liabilities
Long-term liabilities
Lease obligations
Guarantee deposits received
Deferred tax liabilities
Net defined benefit liability
Other
Total long-term liabilities
Total liabilities
NET ASSETS
Shareholders’ equity
Common stock
Retained earnings
Treasury stock
Total shareholders’ equity
Accumulated other comprehensive income
Net unrealized gain on other securities
Foreign currency translation adjustments
Remeasurements of defined benefit plans, net of tax
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets- 7 -(Millions of yen)
As ofJune 30, 2024

2,903
87
3,012
2,146
97
2,258
10,506

3,423
86
2,539
2,671
55
2,286
11,064827
11,583461
534
127
13,53424,040763
11,251705
532
125
13,37824,4437,319
43,312(1)
50,6297,319
40,289(1)
47,606

1,607
558
(5)
2,160
415
53,20577,246

2,045
769
(0)
2,814
578
50,99975,443

(2) Quarterly consolidated statements of income and comprehensive income
Quarterly consolidated statements of income
First nine months of the fiscal year ending September 30, 2024
Nine months ended
June 30, 2023
46,882
14,50332,37823,597
8,781

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating income
Non-operating income
Interest income
Dividend income
Gain on currency translation
Other
Total
Non-operating expenses
Loss on currency translation
Other
Total
Ordinary income
Extraordinary income
Gain on sale of fixed assets
Total
Extraordinary losses
Loss on disposal of fixed assets
Total
Income before income taxes
Income taxes – basic
Income taxes – deferred
Total
Net income
Net income attributable to non-controlling interests
Net income attributable to owners of the parent- 8 -(Millions of yen)
Nine months ended
June 30, 2024
48,23815,40932,82923,813
9,015

21
21
－

32
23
19

140
184

78
153

6

－

0
6
8,959

0
0
9,169

7
7

16
16

3
3
8,963
3,698
436
4,134
4,828
132
4,695

0
0
9,185
4,147
423
4,570
4,615
124
4,490

Quarterly consolidated statements of comprehensive income
First nine months of the fiscal year ending September 30, 2024

Net income
Other comprehensive income
Net unrealized gain on other securities
Foreign currency translation adjustments
Remeasurements of defined benefit plans, net of tax
Total
Comprehensive income(Breakdown)Comprehensive income attributable to owners of the parent
Comprehensive income attributable to non-controlling interests- 9 -Nine months ended
June 30, 2023
4,828(Millions of yen)
Nine months ended
June 30, 2024
4,615

604
14
2
622
5,450

438
250
5
693
5,309

5,322
128

5,145
163

(3) Quarterly consolidated statements of cash flows
Nine months ended
June 30, 2023
Cash flows from operating activities
Income before income taxes
Depreciation
Amortization of goodwill
Increase (decrease) in reserve for doubtful accounts
Increase (decrease) in reserve for bonuses
Increase (decrease) in net defined benefit asset and liability
Increase (decrease) in accounts payable due to transition to aretirement benefit planInterest and dividends received
Loss (gain) on currency translation
Loss (gain) on sales of disposal of non-current assets
Decrease (increase) in trade receivables
Decrease (increase) in inventories
Increase (decrease) in trade payables
Increase (decrease) in guarantee deposits
Other
SubtotalInterest and dividends received
Income tax (paid) refunded
Net cash provided by (used in) operating activities
Cash flows from investing activities
Expenditure for deposit to time deposits
Proceeds from withdrawal of time deposits
Purchase of investment securities
Purchase of property, plant and equipment
Proceeds from sale of property, plant and equipment
Purchase of intangible assets
Net cash provided by (used in) investing activities
Cash flows from financing activities
Purchase of treasury stock
Cash dividends paid
Other
Net cash provided by (used in) financing activities
Effects of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of the period
Cash and cash equivalents, end of the period- 10 -(Millions of yen)
Nine months ended
June 30, 2024

8,963
869
23
(0)
(47)
10

9,185
712
23
(2)
(42)
(2)

(992)

(828)

(43)
2
(3)
(501)
(790)
331
(334)
328
7,813
35
(1,894)
5,954

(56)
(9)
(16)
207
(171)
497
(331)
384
9,551
54
(2,072)
7,533

(196)
196
(1)
(537)
10
(315)
(844)

(197)
2,697
(1)
(409)
28
(336)
1,781

－
(7,340)(71)(7,411)(1)(2,303)29,53027,226(0)(7,520)(64)(7,585)196
1,925
26,16628,091

(4) Notes to the quarterly consolidated financial statements(Note on assumptions for going concern)
Not applicable(Note on significant changes in the amount of shareholders’ equity)
Not applicable- 11 -

(Note on segment information)
I

Consolidated results for the first nine months of the fiscal year ending September 30, 2023
(October 1, 2022 to June 30, 2023)
1. Net sales and income (loss) data, by reportable segment

Net sales
Revenue from contracts
with customers
Other revenue
Sales, externalIntersegment sales
Total
Segment income

Cosmetics

Pharmaceuticals&
Health Food

36,600

8,646

Other

1,573

Total

46,821(Millions of yen)Amounts
included inquarterly
Adjustment
consolidated(Note 1)statements ofincome(Note 2)－

46,821

－
－
61
61
－
61
36,6008,646
1,634
46,882－
46,882
－
－
209
209
(209)
－
36,6008,646
1,844
47,091(209)
46,882
9,326
1,003
167
10,498(1,716)
8,781(Note 1) Intersegment eliminations totaling 402 million yen and unallocated corporate expenses totaling(2,119) million yen have been included in the segment income adjustment totaling (1,716)
million yen. Corporate expenses refer to Noevir Holdings Co., Ltd.’s administration costs, which
do not come under any reportable segments.
(Note 2) Segment income refers to operating income as reported in the quarterly consolidated statements
of income, after adjustment.

2. Impairment loss for non-current assets and goodwill, by reportable segment
Not applicable- 12 -

II

Consolidated results for the first nine months of the fiscal year ending September 30, 2024
(October 1, 2023 to June 30, 2024)
1. Net sales and income (loss) data, by reportable segment

Net sales
Revenue from contracts
with customers
Other revenue
Sales, externalIntersegment sales
Total
Segment income

Cosmetics

Pharmaceuticals&
Health Food

38,099

8,265

Other

1,807

Total

(Millions of yen)Amounts
included inquarterly
Adjustment
consolidated(Note 1)statements ofincome(Note 2)

48,172－

48,172

－
－
66
66
－
66
38,0998,265
1,873
48,238－48,238
－
－
203
203
(203)
－
38,0998,265
2,077
48,442(203)
48,238
9,606
954
222
10,783(1,767)
9,015(Note 1) Intersegment eliminations totaling 400 million yen and unallocated corporate expenses totaling(2,168) million yen have been included in the segment income adjustment totaling (1,767)
million yen. Corporate expenses refer to Noevir Holdings Co., Ltd.’s administration costs, which
do not come under any reportable segments.
(Note 2) Segment income refers to operating income as reported in the quarterly consolidated statements
of income, after adjustment.

2. Impairment loss for non-current assets and goodwill, by reportable segment
Not applicable- 13 -